Metraipolis › archive › dc_c7945575bd52

Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis — Europe PMC PMID:41141191

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41141191
DOI
10.7759/cureus.93065
License (as archived)
solo-consultazione
Archived
2026-11-09T19:34:04.872Z
SHA-256 of the archived text
950f50ab205814d9b49e77383308b7b40968fcafe9a8c93b2892259b0ae4df55
Stable URL of this page
https://metraipolis.com/documento/dc_c7945575bd52

How to cite

Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis — Europe PMC PMID:41141191 — Europe PMC (en), https://europepmc.org/article/MED/41141191 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7945575bd52 (Metraipolis archive dc_c7945575bd52, sha256 950f50ab205814d9b49e77383308b7b40968fcafe9a8c93b2892259b0ae4df55)
BibTeX
@misc{dcc7945575bd52,
  title = {Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis — Europe PMC PMID:41141191},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41141191},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7945575bd52; sha256 950f50ab205814d9b49e77383308b7b40968fcafe9a8c93b2892259b0ae4df55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41141191. Agents can read the archived copy with the MCP tool read_document.